Related Experiment Video
Updated: May 18, 2026
08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Bariatric surgery or medicine for type 2 diabetes?
Sheila A Doggrell1, Vincent Chan
1Queensland University of Technology, School of Biomedical Science, Faculty of Health, QLD4001, Brisbane, Australia. sheila.doggrell@qut.edu.au
Expert Opinion on Pharmacotherapy
|September 11, 2012
Summary
Bariatric surgery is more effective than medical treatment for resolving type 2 diabetes in obese patients. Further research is needed to compare specific surgical procedures and their associated risks.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Surgical Innovation
Background:
- Type 2 diabetes is a prevalent metabolic disorder often managed with diet and medication.
- Obesity is a significant comorbidity associated with type 2 diabetes.
- Bariatric surgery has emerged as a potential intervention for diabetes management in obese individuals.
Purpose of the Study:
- To evaluate the efficacy of bariatric surgery compared to medical treatment for type 2 diabetes.
- To synthesize findings from clinical trials comparing surgical and non-surgical interventions for diabetes resolution.
Main Methods:
- Review and analysis of two major clinical trials: the Surgical Treatment And Medications Potentially Eradicate Diabetes Efficiently (STAMPEDE) trial and the DIet and medical therapy versus BAriatric SurgerY in type 2 diabetes (DIBASY) trial.
- Comparison of outcomes between different bariatric procedures (laparoscopic Roux-En Y gastric bypass, sleeve gastrectomy, laparoscopic gastric bypass, biliopancreatic-diversion) and conventional medical therapy.
Main Results:
- Both STAMPEDE and DIBASY trials demonstrated superior effectiveness of bariatric surgery over medical care in resolving or managing type 2 diabetes.
- Surgical interventions showed significant improvements in diabetes control compared to diet and medication alone.
Conclusions:
- Bariatric surgery represents a highly effective treatment option for type 2 diabetes in obese patients.
- Further large-scale studies are warranted to determine the comparative effectiveness of different bariatric procedures and to assess their long-term risks versus benefits.
Related Concept Videos
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...